Citation only
via Europe PMC
Functional rejuvenation of endothelial cell aging by transient reprogramming.
Kalies K, Knoepp K, Hehl L, Guerlach S, Sandiano L, Simm A, Dutzmann J, Sedding D.
Basic research in cardiology · 2026
Telomere attrition
Cellular senescence
Partial reprogramming (OSK)
Cell culture / in vitro
Human
Mouse
In vitro
Abstract
Senescent endothelial cells (ECs), characterized by a reduced angiogenic and regenerative potential, are key players in the pathophysiology of cardiovascular diseases. Therefore, targeting these cells has been suggested as an effective therapeutic strategy to increase health. Here, we are the first to report that non-genetic overexpression of the Yamanaka factors induces partial functional rejuvenation and attenuation of senescence(definition)-associated features in endothelial cells. Methods to characterize the effects of the transient reprogramming included quantification of gene expression as well as measurements of cellular functions in vitro. Further, in vivo experiments were performed in a hind-limb ischemia model. The application of the pharmacological cocktail to replicative senescent ECs resulted in a robust but timely restricted activation of Oct3/4, Sox2, Klf4, and c-Myc (p < 0.0 and p < 0.01). This was associated with a significant reduction of senescence markers such as p16ink4a and p14arf (p < 0.01). Additionally, qPCR-based telomere(definition) length measurements were stabilized, and functional properties of senescent ECs, such as proliferation, migration, sprouting, and tube formation, were improved (p < 0.05). Continuous cultivation of the treated cells over the long term indicated that expression of p16ink4a and p14arf remained significantly low, while cell migration remained enhanced. In vivo, a significantly improved blood flow was observed at 7 and 14 days after hind-limb ischemia in 21 months old C57BL/6 mice (p < 0.001). In conclusion, we revealed that a partial attenuation of endothelial cell senescence-associated features can be induced by a short pharmacological overexpression of the Yamanaka factors. While the compounds used are individually approved for other indications, their combined use in this context highlights a conceptual translational potential, whereas the clinical applicability of this approach remains to be evaluated.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s00395-026-01192-7
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
K, K., K, K., L, H., S, G., L, S., A, S., J, D., & D., S. (2026). Functional rejuvenation of endothelial cell aging by transient reprogramming. <em>Basic research in cardiology</em>. https://doi.org/10.1007/s00395-026-01192-7
Vancouver
K K, K K, L H, S G, L S, A S, et al. Functional rejuvenation of endothelial cell aging by transient reprogramming. Basic research in cardiology. 2026. doi:10.1007/s00395-026-01192-7.
BibTeX
@article{kalies2026Functi,
title = {Functional rejuvenation of endothelial cell aging by transient reprogramming.},
author = {Kalies K and Knoepp K and Hehl L and Guerlach S and Sandiano L and Simm A and Dutzmann J and Sedding D.},
journal = {Basic research in cardiology},
year = {2026},
doi = {10.1007/s00395-026-01192-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Basic Research in Cardiology 2026
Open access · CC-BY
Functional rejuvenation of endothelial cell aging by transient reprogramming
Aging Cell 2023
Open access · CC-BY
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Stem Cell Research & Therapy 2018
Open access · CC-BY
Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison
International Journal of Molecular Sciences 2021
Open access · CC-BY
Radiation-Induced Osteocyte Senescence Alters Bone Marrow Mesenchymal Stem Cell Differentiation Potential via Paracrine Signaling
PLoS ONE 2008
Open access · CC-BY
Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process
Clinical and Translational Medicine 2022
Open access · CC-BY